Back to top

Eton Pharmaceuticals initiated with a Buy at Canaccord

Canaccord last night initiated coverage of Eton Pharmaceuticals (ETON) with a Buy rating and $60 price target The firm says Eton is evolving into a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Eton Pharmaceuticals, Inc. (ETON)